Upfront surgery for advanced ovarian cancer failed to improve overall survival (OS) versus interval debulking but did improve ...

Olawaiye noted that the combination is a "well-tolerated regimen and we believe it should be a new standard for ...

Primary surgery for advanced ovarian cancer significantly improves progression-free survival but not overall survival ...

Adding relacorilant to nab-paclitaxel improved survival outcomes in patients with platinum-resistant ovarian cancer.

Ovarian cancer isn't silent - learn the early warning signs. Persistent bloating, pelvic pain, urinary symptoms revealed.

Relacorilant blocks GR activation, a key pathway driving stress-induced chemoresistance in ovarian cancer cells.

It’s often diagnosed at a late stage. But with a new blood test, scientists believe that survival rate could soar.

Michele Hoaglund, who bought the store about a decade ago from its founding owners, was diagnosed with ovarian cancer around ...

US-based biotechnology company Imunon has reported positive results from its Phase II OVATION 2 trial of IMNN-001 for ovarian ...

Around one in 10 women will develop ovarian cysts at some point during their lives, and while the prospect of a cyst growing ...